Corpus Intelligence IC Memo — BRIGHAM CITY COMMUNITY HOSPITAL 2026-04-26 04:03 UTC
IC Memo — BRIGHAM CITY COMMUNITY HOSPITAL
Investment Committee Memorandum | UT | 40 beds | Grade C | EBITDA uplift $3.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BRIGHAM CITY COMMUNITY HOSPITAL

CCN 460017 | BOX ELDER, UT | 40 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

BRIGHAM CITY COMMUNITY HOSPITAL is a 40-bed suburban community hospital in BOX ELDER, UT with $44.9M in net patient revenue and a 31.1% operating margin. The hospital serves a payer mix of 18.2% Medicare, 4.8% Medicaid, and 77.0% commercial.

Thesis: Turnaround. Our ML models identify $3.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 31.1% to 38.5% (+736bps).

Net Revenue HCRIS$44.9M
Current EBITDA COMPUTED$14.0M
Operating Margin COMPUTED31.1%
Occupancy HCRIS17.6%
Revenue / Bed COMPUTED$1.1M
Net-to-Gross HCRIS23.9%
Distress Probability ML54.6%

2. Market Context & Competitive Position

59
UT Hospitals
8.0%
State Median Margin
25
Comparable Hospitals

UT has 59 Medicare-certified hospitals with a median operating margin of 8.0%. The target's margin of 31.1% places it above the state median. Among 25 size-comparable peers (20-80 beds), the median margin is 4.3%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (20-80), prioritizing same-state peers. 25 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BRIGHAM CITY COMMUNITY HOSPITA (Target)UT40$44.9M31.1%
CEDAR CITY HOSPITALUT48$136.8M31.4%
LONE PEAK HOSPITALUT61$133.1M25.2%
ALTA VIEW HOSPITALUT57$130.9M-0.6%
GUNNISON VALLEY HOSPITALUT25$130.4M-6.4%
LAYTON HOSPITALUT37$121.1M9.5%
PARK CITY HOSPITALUT37$120.8M13.7%
UINTAH BASIN MEDICAL CENTERUT33$119.9M1.8%
MOUNTAIN WEST MEDICAL CENTERUT36$96.1M38.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$942K+210bp18mo
Cost to Collect4.5%2.5%$897K+200bp12mo
Denial Rate Reduction12.0%6.5%$888K+198bp12mo
A/R Days Reduction5200.0%3800.0%$546K+122bp9mo
Clean Claim Rate88.0%96.0%$29K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$942K
Cost to Collect
$897K
Denial Rate Reduction
$888K
A/R Days Reduction
$546K
Clean Claim Rate
$29K
Total EBITDA Uplift$3.3M
Current EBITDA$14.0M
+ RCM Uplift+$3.3M
Pro Forma EBITDA$17.3M
Current Margin31.1%
Pro Forma Margin38.5%
WC Released (1x)$1.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$21.5M$125.1M5.83x42.3%
Base (11x exit)10.0x11.0x$21.5M$144.6M6.73x46.4%
Bull Case9.0x11.0x$19.3M$162.4M8.41x53.1%
Bull (12x exit)9.0x12.0x$19.3M$182.9M9.47x56.8%
Bear Case11.0x10.0x$23.6M$101.6M4.30x33.9%
Bear (11x exit)11.0x11.0x$23.6M$119.4M5.06x38.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 17.6%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 54.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 25 hospitals with 20-80 beds
  • Same-state prioritization (n=26)
  • Comp margins: P25=-12.4% / P50=4.3% / P75=14.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.